Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study.
Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. Osteoporos Int. 2006 Feb; 17(2):225-30.